Author: healthprofessionalradio

Presenter: Neal Howard
Guest: Karen Leonetti
Guest Bio: Karen Leonetti holds child development associate and child development specialist degrees. An educator for 20 years, she ran the only 100 percent green, organic school in Florida for 17 years. She has extensively researched healing through diet and alternative therapies. Her children’s book, Yummy, tummy, Rainbow Garden is designed to get kids excited about healthy foods.

Segment Overview
Karen Leonetti discusses healthy eating and how it can help a family to bond and foster positive mental health.

Presenter: Neal Howard
Guest: Karen Leonetti
Guest Bio: Karen Leonetti holds child development associate and child development specialist degrees. An educator for 20 years, she ran the only 100 percent green, organic school in Florida for 17 years. She has extensively researched healing through diet and alternative therapies. Her children’s book, Yummy, tummy, Rainbow Garden is designed to get kids excited about healthy foods.

Segment Overview
Karen Leonetti talks about “Yummy, Tummy, Rainbow Garden” and how sitting down to the table to eat as a family helps children develop mentally.

Presenter: Neal Howard
Guest: Linda Naomi Katz
Guest Bio: Linda Naomi Katz born on March 21, 1969. After she graduated college, she was diagnosed with bipolar disorder. Through the years she was faced with challenges that were difficult to overcome, but worked hard to achieve recovery. As part of her recovery from mental illness, Linda became a member of NAMI (National Alliance on Mental Illness) and published articles about her life in New York City Voices, a newspaper for people with mental illness to share their personal recovery stories. Linda is happily married, an author who has published a book titled Surviving Mental Illness, My Story which won a Silver Medal Award by Readers Favorite for best non-fiction/autobiography and came in First Place and won the Life Journeys Award for best memoir/biography from Readers Views. Through this book she describes all of her challenges that she dealt with while having a mental illness and how she found her way back towards establishing a wellness by staying mentally and physically strong.

Segment Overview
Linda Katz discusses how she grew up with mental illness in her family life and how undiagnosed bi-polar disorder affected her early adulthood.

Presenter: Neal Howard
Guest: Linda Naomi Katz
Guest Bio: Linda Naomi Katz born on March 21, 1969. After she graduated college, she was diagnosed with bipolar disorder. Through the years she was faced with challenges that were difficult to overcome, but worked hard to achieve recovery. As part of her recovery from mental illness, Linda became a member of NAMI (National Alliance on Mental Illness) and published articles about her life in New York City Voices, a newspaper for people with mental illness to share their personal recovery stories. Linda is happily married, an author who has published a book titled Surviving Mental Illness, My Story which won a Silver Medal Award by Readers Favorite for best non-fiction/autobiography and came in First Place and won the Life Journeys Award for best memoir/biography from Readers Views. Through this book she describes all of her challenges that she dealt with while having a mental illness and how she found her way back towards establishing a wellness by staying mentally and physically strong.

Segment Overview
Linda Katz discusses the stigma attached to bi-polar disorder and mental illness as a whole. She also talks about how she dealt with her own biases against mental illness through volunteer work and writing.

Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.

Segment Overview
Dr. Stephen Shrewsbury discusses “gene patch” technology and how it could potentially stop disease and other ailments.

Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.

Segment Overview
Dr. Stephen Shrewsbury discusses some of the ethical questions that could arise as gene patch technology progresses.

Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.

Segment Overview
Dr. Stephen Shrewsbury discusses his book “Defy your DNA” and also further addresses ethical considerations pertaining to aging.